Buy On Lazada

Buy on Qoo10

Buy on SHOPEE

Join us as a reseller WITHIN SINGAPORE

• Description
  
• Specifications
  
• Request

<

>

COATS® (an acronym for colloidal oatmeal system) is a patented and unique nitrile glove technology.

COATS® utilises the powerful benefits of all-natural oats, an FDA-recognised skin protectant, as a coating that forms a natural, moisturising barrier between the glove and skin. This acts as a preventative measure against skin irritation, and eliminates many of the uncomfortable and irritating conditions experienced when wearing normal gloves.

Users who suffer from dry and itchy skin due to constant hand washing and glove usage can now rely on COATS® to soothe and nurture the skin, and protect their hands while they work.

​Features:

• Fingertip textured
• Powder free
• Food safe
• Not made with natural rubber latex
• Chemo drugs tested
• Lab chemical tested
• Ambidextrous
• Standard cuff
• Dawn blue colour

    Sizes

• X-Small
• Small
• Medium
• Large
• X-Large

 Packaging Information
100 Gloves per box (All sizes except XL)
90 Gloves per box (XL Only)
10 Boxes per carton

Dimensions in millimetres.

Glove Properties	Measurement (mm)
Length (mm)	≥ 230
Thickness at Palm (centre of Palm)	0.07 ± 0.02
Thickness at Finger (13mm ± 3mm from tip)	​0.09 ± 0.02

Physical Properties	Before Ageing	After Ageing
Tensile Strength (MPa)	≥ 18	≥ 16
Elongation (%)	≥ 500	≥ 400

Chemical	EN 16523-1:2015 Permeation Level	EN 374-4:2013 Mean Degradation (%)
K    40% Sodium Hydroxide	6	-0.7
T     37% Formaldehyde	4	21.1

Inspection Levels & AQL	Inspection Level	AQL
Watertightness	G1	1.5
Physical Dimensions	S2	4.0
Physical Properties	S2	4.0
Visual Inspection (Major)	S4	2.5
Visual Inspection (Minor)	S4	4.0
Particulate Residue	N = 5	≤ 2mg/glove
Colloidal Oatmeal Content	N = 5	​≥ 5mg/glove

Measured breakthrough time (Minutes)	Permeation performance level
>10	1
>30	2
>60	3
>120	4
>240	5
>480	6

REGULATORY COMPLIANCE	STANDARDS	MANUFACTURING ACCREDITATION	PATENTS
ARTG 164563 FDA 510(k) EU 2016/425 REACH EU 10/2011 EC 1935/2004 MDR (EU) 2017/745 ​ ​ ​	ASTM D6319 ASTM D6124 ASTM D5151 ASTM F1671 ASTM D6978 CEN/TS 14234 EN 455 part 1, 2, 3 & 4 EN 1186 EN 13130 EN ISO 374-1 (Type C) EN 16523-1 EN 420 EN 374 part 2, 3, 4 & 5 ISO 10993 part 5 & 10	ISO 9001 ISO 13485 EN ISO 13485 ​ ​ ​	Patent 7,691,436 Patent 7,718,240 Patent 7,740,622 Patent 8,075,965 Patent 8,458,818

Chemotherapy Drugs and Concentration (Tested for Resistance to Permeation by Chemotherapy Drugs as per ASTM D6978-05-Test Report PN 104145B)	Minimum Breakthrough Detection Time (minutes)
Carmustine (BCNU), 3.3mg/ml (3,300 ppm)	Not recommended
Cisplatin, 1.0mg/ml (1,000 ppm)	> 240 minutes
Cyclophosphamide (Cytoxan), 20.0mg/ml (20,000 ppm)	> 240 minutes
Dacarbazine (DTIC), 10.0mg/ml (10,000 ppm)	> 240 minutes
Doxorubicin Hydrochloride, 2.0mg/ml (2,000 ppm)	> 240 minutes
Etoposide (Toposar), 20.00mg/ml (20,000 ppm)	> 240 minutes
Fluorouracil, 50.0mg/ml (50,000 ppm)	> 240 minutes
Methotrexate, 25.0mg/ml (25,000 ppm)	> 240 minutes
Mitomycin C, 0.5mg/ml (500 ppm)	> 240 minutes
Paclitaxel (Taxol), 6.0mg/ml (6,000 ppm)	> 240 minutes
Thiotepa, 10.0mg/ml (10,000 ppm)	Not recommended
Vincristine Sulfate, 1.0mg/ml (1,000 ppm)	> 240 minutes

Videos